Evidence map›Paper›PMID 36630829›Full record

ArticleComputers in biology and medicine2023

More or less deadly? A mathematical model that predicts SARS-CoV-2 evolutionary direction.

Zhaobin Xu, Dongqing Wei, Qiangcheng Zeng, Hongmei Zhang, Yinghui Sun, Jacques Demongeot

Abstract read
In one paragraph

Article in Computers in biology and medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhaobin XuDepartment of Life Science, Dezhou University, Dezhou, 253023, China. Electronic address: xuzhaobin@dzu.edu.cn.
Dongqing WeiSchool of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, 200030, China.
Qiangcheng ZengDepartment of Life Science, Dezhou University, Dezhou, 253023, China.
Hongmei ZhangDepartment of Life Science, Dezhou University, Dezhou, 253023, China.
Yinghui SunDepartment of Life Science, Dezhou University, Dezhou, 253023, China.
Jacques DemongeotLaboratory AGEIS EA 7407, Team Tools for e-Gnosis Medical, Faculty of Medicine, University Grenoble Alpes (UGA), 38700, La Tronche, France. Electronic address: Jacques.Demongeot@univ-grenoble-alpes.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SARS-CoV-2 has caused tremendous deaths globally. It is of great value to predict the evolutionary direction of SARS-CoV-2. In this paper, we proposed a novel mathematical model that could predict the evolutionary trend of SARS-CoV-2. We focus on the mutational effects on viral assembly capacity. A robust coarse-grained mathematical model is constructed to simulate the virus dynamics in the host body. Both virulence and transmissibility can be quantified in this model. A delicate equilibrium point that optimizes the transmissibility can be numerically obtained. Based on this model, the virulence of SARS-CoV-2 might further decrease, accompanied by an enhancement of transmissibility. However, this trend is not continuous; its virulence will not disappear but remains at a relatively stable range. A virus assembly model which simulates the virus packing process is also proposed. It can be explained why a few mutations would lead to a significant divergence in clinical performance, both in the overall particle formation quantity and virulence. This research provides a novel mathematical attempt to elucidate the evolutionary driving force in RNA virus evolution.

Indexed as

COVID-19SARS-CoV-2HumansModels, TheoreticalEvolution directionMathematical modelingSARS-CoV-2TransmissibilityVirulence

Identifiers

PMID36630829
PMCPMC9816089

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.